Related Experiment Video
Updated: Apr 18, 2026
06:59
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
Published on: June 13, 2016
11.0K
MicroRNAs and benign biliary tract diseases.
Sergio A Gradilone1, Steven P O'Hara1, Tetyana V Masyuk1
1Division of Gastroenterology and Hepatology, and the Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, Minnesota.
Seminars in Liver Disease
|January 31, 2015
Summary
MicroRNAs (miRNAs) are key regulators in liver diseases affecting bile ducts (cholangiopathies). Understanding miRNA roles offers new diagnostic and prognostic insights for these complex biliary tract conditions.
Area of Science:
- Hepatology
- Molecular Biology
- Genetics
Background:
- Cholangiocytes are crucial liver cells responsible for bile secretion.
- Cholangiopathies, diseases of the biliary tract, often have unclear pathological mechanisms.
- MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression posttranscriptionally.
Purpose of the Study:
- To review the role of miRNAs in the pathogenesis of cholangiopathies.
- To discuss the diagnostic and prognostic potential of miRNAs in biliary tract diseases.
- To suggest future research directions for miRNA-based therapies.
Main Methods:
- Literature review of recent studies on miRNAs and cholangiopathies.
- Analysis of miRNA profiles in fibroinflammatory cholangiopathies and polycystic liver diseases.
- Discussion of miRNA dysregulation in biliary tract pathobiology.
Main Results:
- Altered miRNA profiles are implicated in the dysregulation of proteins in cholangiopathies.
- miRNAs show promise as diagnostic and prognostic biomarkers for liver diseases.
- Specific miRNAs are involved in the etiopathogenesis of fibroinflammatory and polycystic liver diseases.
Conclusions:
- miRNAs play a significant role in the development and progression of cholangiopathies.
- miRNA analysis offers valuable tools for diagnosing and predicting outcomes in biliary tract diseases.
- Further research into miRNA mechanisms is essential for advancing cholangiopathy treatment.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
01:17Chronic Bowel Disorders: Introduction
952
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
952
01:23Cirrhosis I: Introduction
3
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
3
01:20Cholecystitis
3
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
3
01:28Fungal Phylum Microsporidia
767
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
767